Q3 2020
Released Oct 26, 2020, after the close
10-Q filed Oct 26, 2020, 26 days after period end · 0001564590-20-047628
Q3 2020 · 10-Q
Revenue—
Net Income-$3.70M-$3.70M N/M vs Q3 2019N/M vs Q2 2020
EPS Diluted-$0.08-$0.08 N/M vs Q3 2019N/M vs Q2 2020
Operating Income-$3,730,016N/M
Operating Cash Flowderived-$3,908,098N/M
Free Cash Flowderived-$3,909,288N/M
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2020 | Q3 2019 | Q3 2018 | Q3 2017 |
|---|---|---|---|---|
| Net Income | -$3.70M | -$2.38M | -$6.78M | -$3.76M |
| EPS Diluted | -$0.08 | -$0.05 | -$0.16 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR